Hadley J. Sharp, MD

Hadley J. Sharp, MD

workRadiation Oncologist
location_onAtrium Health – Levine Cancer Institute – University Radiation Therapy Center

About Dr. Sharp

Hadley Sharp MD believes in partnering with patients to provide the highest quality of care. Prior to joining SERO, Dr. Sharp conducted research at the National Cancer Institute and MD Anderson Cancer Center. Her clinical interests include stereotactic radio surgery, IMRT and brachytherapy. She treats all tumor types. Dr. Sharp presents at national meetings, authors peer reviewed publications and conducts clinical trials. Committed to excellence in patient care, Dr. Sharp is welcoming new patients.

"I treat all patients with care and compassion and appreciate the opportunity to participate in your care."

Dr. Sharp

Professional Organizations

American Society of Clinical Oncology, 3/2010- present

American Society of Radiation Oncology, 11/2008-present

Advocacy Day Resident Participant, 3/2010

American Association for Women in Radiology, 1/2010-present

Member in Training Committee Member

North Carolina Medical Society, 2012-present

Mecklenburg County Medical Society, 2012-present

South Carolina Medical Society, 2012-present


Awards & Affiliations


Education

University of Texas M.D. Anderson Cancer Center

2008 — 2012

Austin, TX

Clinical Radiation Oncology Residency

St. Joseph Exempla Hospital

2007 — 2008

Denver, CO

Clinical Internship

Howard Hughes Medical Institute

2005 — 2006

Bethesda, MD

Fellowship
HHMI-NIH Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health

University of Nebraska College of Medicine

2007

Omaha, NE

MD with honors

Creighton University

2002

Omaha, NE

B.S., Medical Mathematics


Publications

Find Dr. Sharp’s full list of publications on PubMed here.

Invited Articles


Selected Meeting Presentations

  • Human Omental-Derived Adipose Stem Cells Decrease Ovarian Tumor Radiosensitivity and Promote Ovarian Tumor Proliferation, Migration and Growth. ASTRO Annual Meeting, Miami, 10/2011
  • Prostate Brachytherapy Preceded by Screening Colonoscopy Diagnoses Colorectal Cancers in Asymptomatic Patients. Texas Radiologic Society 3/2010
  • Radiation and Immunotherapy. Presentation, HHMI Scientific Discovery Banquet, Bethesda, Maryland, 4/2006
  • Combination strategies with Iodine-125 brachytherapy and recombinant poxvirus vaccine., Laboratory of Tumor Immunology and Biology, NCI, NIH, Bethesda, Maryland, 5/2006
  • Use of Iodine-125 brachytherapy and recombinant poxvirus cancer vaccine to increase tumor cell killing in vitro and in vivo., International Students Forum-Chinese Academy of Science, Beijing, China, 6/2006
  • Active antigen specific systemic immunotherapy combined with brachytherapy in the treatment of carcinomas., Grand Rounds, Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, 6/2006
  • High incidence of oral dysesthesias on a trial of gefitinib, palcitaxel, and concurrent external beam radiation for locally advanced head and neck cancers., ASTRO Annual Meeting, Philadelphia, Pennsylvania, 11/2006

Abstracts

  • Feasibility of Radiosurgical Decompression of Metastatic Epidural Spinal Cord Compression (MESCC) in Nonoperable Patients. ASTRO Annual Meeting, Boston, 10/2012
  • Concurrent Temozolomide and Radiation in Elderly Patients with Glioblastoma: a Retrospective Analysis. ASTRO Annual Meeting, Miami, 10/2011
  • Human omental-derived adipose stem cells support growth of intra-peritoneal ovarian cancer xenografts and increase proliferation and migration of ovarian cancer cells. AACR Annual Meeting, Orlando 3/2011
  • The Influence of Race on Presentation and Outcome in Patients Irradiated for Prostate Cancer. American Society of Clinical Oncology, Genitourinary Symposium, San Francisco, 3/2010
  • Prostate Brachytherapy Preceded by Screening Colonoscopy Diagnoses Colorectal Cancers in Asymptomatic Patients. American Radium Society Annual Meeting, Cancun Mexico, 5/2010, Poster of Distinction
  • Combination of brachytherapy and immunotherapy to modulate phenotype and enhance antigen specific killing of tumor cells. HHMI Medical Fellows Meeting, Chevy Chase, Maryland, 5/2006
  • Use of Iodine-125 brachytherapy and recombinant poxvirus cancer vaccine to increase tumor cell killing in vitro and in vivo. ASTRO Annual Meeting, Philadelphia, Pennsylvania, 11/2006
  • Combination of brachytherapy and immunotherapy to modulate phenotype and enhance antigen specific killing of tumor cells, Midwest Student Biomedical Research Forum, Omaha, Nebraska, 3/2007

Invited Lectures

  • UT MDACC Medical Dosimetry Program: Sarcoma and the role of radiation, June 2009
  • UT MDACC Radiation Therapy Program: Gastrointestinal malignancies, May 2010
  • UT MDACC Medical Dosimetry Program: Sarcoma and the role of radiation, June 2010
  • UT MDACC Radiation Therapy Program: Gastrointestinal malignancies, May 2011
  • UT MDACC Medical Dosimetry Program: Brain tumors and radiation, May 2011